Enlivex announces 1-for-15 reverse stock split
Seeking Alpha ·
Enlivex ( ENLV ) said on Tuesday it will implement a 1-for-15 reverse stock split, with shares trading on a split-adjusted basis beginning July 9, 2026. The reverse split will reduce the company's issued and outstanding ordinary shares to approximately 16.8M from 252.5M, while lowering its authorized share count to 158.3M from 2.38B. Fractional shares will be rounded up, with corresponding adjustments to outstanding warrants and options. Seeking Alpha’s Quant Rating on Envilex Therapeutics Historical earnings data for Envilex Therapeutics Financial information for Envilex Therapeutics
DYAX Investor Sentiment
Bullish (Long) 61% · Bearish (Short) 39%
484 participants
Related News
- Waymo to roll out driverless vehicles in four new U.S. cities
- AEP to receive up to $3.26B DoE loan for Texas power grid upgrades
- JPMorgan Chase focuses on small company deals to juice M&A - report
- Nvidia Valuation Falls to Pre-AI Boom Low
- Nvidia rises as it looks to partner with competitors; China reportedly allows sales
- China plans to let top AI firms buy limited amount of Nvidia H200 chips, the Information reports